Pharmacologic Adjuvants to Reduce Erythropoietin Therapy Dose in Anemia of Chronic Kidney Disease and End Stage Renal Disease

Podobne zapisy

• THE ROLE OF ERYTHROPOIETIN IN TREATMENT OF ANEMIA IN CANCER PATIENTS
  od: P. G. Berezin, i wsp.
  Wydane: (2017-06-01)
• Erythropoietin for the treatment of anemia in patients with hematologic disorders
  od: R. A. Podgurskaya, i wsp.
  Wydane: (2022-11-01)
• Recombinant erythropoietin in the treatment of anemia in cancer patients
  od: S. V. Vorobiova, i wsp.
  Wydane: (2022-11-01)
• Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy
  od: Yu. V. Semenova, i wsp.
  Wydane: (2024-04-01)
• Cardiovascular Disease in End Stage Renal Disease Patients
  od: Haragsim, Lukas, i wsp.
  Wydane: (2011)